These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 185688)

  • 1. Unified mass-action theory for virus neutralization and radioimmunology.
    Trautman R
    Scand J Immunol; 1976; 5(6-7):609-22. PubMed ID: 185688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of some immunological methods for the differentiation of strains of foot-and-mouth disease virus.
    Forman AJ
    J Hyg (Lond); 1975 Apr; 74(2):215-25. PubMed ID: 164500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of block neutralization test curves into components of the foot-and-mouth disease virus system.
    Trautman R
    Arch Virol; 1979; 60(3-4):257-64. PubMed ID: 92300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of foot-and-mouth disease virus. I. Sensitization of the 140S virion by antibody also reactive with the 12S protein subunit.
    Hardy MM; Moore DM
    J Gen Virol; 1981 Aug; 55(Pt 2):415-27. PubMed ID: 6169797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization kinetics studies with type SAT2 foot-and-mouth disease virus strains. 1. Factors that influence the rate and pattern of neutralization.
    Rweyemamu MM; Booth JC; Pay TW
    J Hyg (Lond); 1977 Feb; 78(1):99-112. PubMed ID: 13123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent structural solutions for antibody neutralization of viruses.
    Stewart PL; Nemerow GR
    Trends Microbiol; 1997 Jun; 5(6):229-33. PubMed ID: 9211643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling and computer stimulation approach to the mechanism of foot-and-mouth disease virus neutralization assays.
    Trautman R; Harris WF
    Scand J Immunol; 1977; 6(8):831-41. PubMed ID: 197591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relationships in foot-and-mouth disease virus.
    Brown F
    Adv Exp Med Biol; 1972; 31(0):19-28. PubMed ID: 4369223
    [No Abstract]   [Full Text] [Related]  

  • 9. Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses.
    Rweyemamu MM; Pay TW; Parker MJ
    Dev Biol Stand; 1976; 35():205-4. PubMed ID: 198288
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of the antigenic structure of foot-and-mouth disease virus to the process of infection.
    Rowlands DJ; Sangar DV; Brown F
    J Gen Virol; 1971 Oct; 13(1):85-93. PubMed ID: 4331815
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants.
    Stave JW; Card JL; Morgan DO; Vakharia VN
    Virology; 1988 Jan; 162(1):21-9. PubMed ID: 2827379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
    Stave JW; Card JL; Morgan DO
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of influenza virus A2-Singapore by antineuraminidase.
    Majer M; Lik F
    J Gen Virol; 1971 Nov; 13(2):355-6. PubMed ID: 5168246
    [No Abstract]   [Full Text] [Related]  

  • 14. Examination of differences between foot-and-mouth disease virus strains using a radioimmunoassay techinque.
    Crowther JR
    Dev Biol Stand; 1976; 35():185-93. PubMed ID: 198286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subtypes of the foot-and-mouth disease virus type O. Their antigenic and immunologic properties and mutual relationships].
    Wittmann G
    Zentralbl Bakteriol Orig; 1964 Sep; 194(1):1-25. PubMed ID: 4284199
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in antigen properties of foot-and-mouth disease virus during several passages].
    Salajov EL; Avilov VS; Revenkov AG
    Bull Off Int Epizoot; 1972; 77(5):935-40. PubMed ID: 4350009
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities and limits of immunochemical methods (radio- and enzyme immunoassay) in testing foot-and-mouth disease vaccine].
    Schilow WF; Reimann I
    Arch Exp Veterinarmed; 1984 Sep; 38(5):697-703. PubMed ID: 6099107
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of a subtype-specific neutralization epitope in foot-and-mouth disease virus of a different subtype.
    Hernández J; Martínez MA; Rocha E; Domingo E; Mateu MG
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():213-6. PubMed ID: 1370534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational alteration in foot-and-mouth disease virus virion capsid structure after complexing with monospecific antibody.
    McCullough KC; Smale CJ; Carpenter WC; Crowther JR; Brocchi E; De Simone F
    Immunology; 1987 Jan; 60(1):75-82. PubMed ID: 3028937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of foot-and-mouth disease virus. II. Further parameters related to the sensitization of the 140S virion by antibody.
    Hardy MM; Moore DM
    J Gen Virol; 1982 Oct; 62 (Pt 2)():287-95. PubMed ID: 6292352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.